Key Proteo, Inc.

Key Proteo, Inc.

Medical Device

Seattle, Washington 320 followers

Changing the Clinical Course of Treatable Rare Genetic Disorders

About us

Key Proteo is democratizing the early detection of rare but treatable genetic disorders through novel and accessible proteomic analysis. As a pioneering proteomics company, Key Proteo is initially focused on the early detection of treatable rare genetic disorders in newborns, with the goal of expanding newborn screening to identify extremely low abundance protein biomarkers that were previously undetectable. Many treatable genetic disorders are difficult to detect, but when found early, intervention can be enabled to help change the clinical course. Ultimately, our mission is to relieve suffering and save lives for patients and their families afflicted by rare but treatable genetic disorders through early screening.

Industry
Medical Device
Company size
2-10 employees
Headquarters
Seattle, Washington
Type
Privately Held
Founded
2019

Locations

Employees at Key Proteo, Inc.

Updates

Similar pages

Funding

Key Proteo, Inc. 2 total rounds

Last Round

Seed

US$ 3.0M

See more info on crunchbase